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Most Western chronic diseases are closely tied to lifestyle behaviors, and many are preventable. Despite the well-distributed
knowledge of these detrimental behaviors, effective efforts in disease prevention have been lacking. Many of these chronic diseases
are related to obesity and type 2 diabetes, which have doubled in incidence during the last 35 years. The Complete Health
Improvement Program (CHIP) is a community-based, comprehensive lifestyle modification approach to health that has shown
success in addressing this problem.This pilot study demonstrates the effectiveness of CHIP in an underserved, rural, and vulnerable
Appalachian population. Twohundred fourteen participants inCHIP collectively demonstrated significant reductions in bodymass
index, systolic and diastolic blood pressure, and fasting blood levels of total cholesterol, low-density lipoprotein, and glucose. If these
results can be repeated in other at-risk populations, CHIP has the potential to help reduce the burden of preventable and treatable
chronic diseases efficiently and cost-effectively.
1. Introduction
Chronic diseases are on the rise, accounting for 84% of the
current national healthcare expenditure [1]. Nearly 18% of
the US Gross Domestic Product, or $2.7 trillion, is now
being spent on healthcare. This is by far more than any
other nation [2]. Many of these chronic diseases have lifestyle
underpinnings and are responsive to lifestyle modification
[3]. It is estimated that nearly 40% of all cancer deaths and
82% of cardiac deaths could be prevented. In addition, 71% of
colon cancer, 71% of strokes, and 91% of the cases of diabetes
could be avoided through appropriate lifestyle changes by
adopting a simpler, healthier diet, by following a consistent
activity program and by avoiding tobacco [4].
The Complete Health Improvement Program (CHIP) [5]
is an intensive community-based lifestyle intervention that
has been shown to offer significant benefits for the preven-
tion, control, and even reversal of cardiovascular disease [6–
8], type 2 diabetes (T2DM) [9, 10], and depression [11, 12].
This program is largely attractive to middle-class people
who are generally employed, have the means to enroll, and
have a level of education that facilitates the understanding,
assimilation, and application of the healthy lifestyle principles
presented in the program.
In Appalachia, Athens County is struggling with the
highest poverty level in Ohio at 35% [13], with nearly 18%
of the population uninsured [14]. Many people in this region
are struggling with issues related to poverty, such as limited
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access to health care, inadequate housing and transportation,
and limited education. Would these challenges hinder their
ability to afford, attend, assimilate, and apply the behavioral
changes taught in CHIP? To address this issue, several
CHIP classes aimed at the general Athens population were
conducted. How would the general population fare when
compared to other CHIP classes across America? And if the
results were comparable, could strategies be developed that
could reach those in the underserved andmarginalized lower
socioeconomic groups in Appalachia? The aim of this pilot
study, then, is to examine the short-term effectiveness of
the CHIP intervention in the general population of Athens
County, Ohio, in Appalachia, for reducing selected chronic
disease risk factors.
2. Methods
The study examined the changes in selected chronic disease
risk factors of 225 self-selected participants who attended one
of six CHIP classes offered in 2011 and 2012 in Athens, Ohio.
Approval for the study was obtained from the local CHIP
administration and the Ohio University Institutional Review
Board.
2.1. Description of CHIP. TheCHIP classes were facilitated by
volunteers trained and authorized by the Lifestyle Medicine
Institute/CHIP throughAthens CHIP andwere administered
locally by Live Healthy Appalachia (LHA), a 501(c)3 organi-
zation, located in Athens, Ohio. Each class was conducted
over a 4- to 8-week period and involved 16 two-hour group
sessions. A typical session included viewing an instructional
video, a cooking demonstration, group discussion, and an
exercise component. The intent of the intervention was to
nurture intelligent self-care through enhanced understand-
ing of the epidemiology, etiology, and risk factors associated
with chronic western diseases.The cost of the course covered
program tuition, two biomedical assessments (performed at
the beginning and near the end of the class), food samples,
textbook, workbook, cookbook, water bottle, pedometer, and
supplementary reading and reference material.
The primary focus of CHIP was the consumption of
whole foods ad libitum, such as fresh fruits, vegetables, whole
grains, legumes, and some nuts. The goal was to keep overall
dietary fat content below 20% of the total calories and the
daily intake of added sugar below 10 teaspoons, sodiumbelow
2,000mg, and cholesterol below 50mg. Water consumption
(at least 8 glasses/day) and high fiber food intake (>35 g/day)
were encouraged, along with flexibility exercises and a daily
walk of 30 minutes, with a goal of reaching 2 miles or 10,000
steps on the pedometer.
Although most classes were conducted in 4 weeks, meet-
ing 4 times a week, a couple of classes were extended to
8 weeks, with fewer meetings per week. The course tuition
increased incrementally over the time frame covered by
the study from $350 to $450. The cost was paid by the
participants, by their employer, by a scholarship, or by any
combination of these. A limited number of scholarships (for
22 of the 225 participants) were provided by local community
organizations and businesses, earmarked for participants
with financial need. Scholarship recipients were selected by
the local CHIP administration based on interest, expression
of need, and eligibility for financial support.
An initial health screen was performed at the beginning
of the course.The results were reviewed with the participants
to help them understand their risk status and to set goals for
the program.
After the second health screen, personal and deidentified
aggregated class health screen results were given to each
participant to see their individual improvements and how
they compared to the group as a whole. This was accom-
panied by a presentation on the meaning of the results and
encouragement to continue with the newly acquired lifestyle
changes. Additional copies of results were provided along
with encouragement to share these with their primary care
provider.
2.2. Study Participants. Study participants were self-selected,
learning about CHIP via announcements in churches and the
local media, or from local health care providers. Potential
CHIP participants attended one of several informational
sessions presented throughout the community on various
dates and times, where they received a mixture of video and
live presentations, had their questions addressed, and were
offered an opportunity to enroll. All participants in CHIP
were informed that their results would be aggregated and
reported for research purposes.Theywere given the option of
having their data excluded without affecting their eligibility
to participate in CHIP. As shown in Table 3, this cohort
at baseline was representative of an at-risk population with
values high in bodymass index (BMI), blood pressure, fasting
lipids, and glucose.
2.3. Data Collection and Reporting. The biomedical assess-
ments included weight, height, systolic blood pressure (SBP),
and diastolic blood pressure (DBP), obtained by trained
medical professionals. Fasting blood samples were collected
by trained phlebotomists and analyzed for total cholesterol
(TC), low-density lipoprotein (LDL), high-density lipopro-
tein (HDL), triglycerides (TG), and plasma glucose (FPG)
utilizing a BeckmanCoulter DXC-600 analyzer in the pathol-
ogy laboratory at O’Bleness Memorial Hospital in Athens,
Ohio, a lab certified by the American College of Pathologists,.
Data for each participant was entered into a password
protected proprietary Access-based database maintained on
the CHIP administration computer at the LHA office as part
of the CHIP routine and separate from the data collection
for this study. For this study, CHIP administration provided
aggregated data from the first six CHIP classes, without
personal identifiers, on a password-protected Excel database
file.
2.4.DataAnalysis. For both overall and stratified data,means
and standard deviations (SD) were computed for each base-
line and postintervention. Mean change (baseline mean −
postintervention mean) and percent (%) mean change (100 ×
mean change/baseline mean) were also computed to show
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Table 1: Comparison of gender and mean age distribution in
participants attending the Athens, OH, CHIP classes versus those
who attended CHIP classes in the US, excluding those attending the
Athens classes (Rankin et al. [8]).
Characteristics Athens Rankin
Total 225 5,066
Male 63 1,694
Female 162 3,372
% male 28 33
% female 72 67
Age: mean (range) 56.0 (24–81) 52.7 (44–71)
magnitudes of changes. One-sample 𝑡-tests were applied to
the % mean changes to test whether these changes were
significant. Cohen’s 𝑑 was computed within each stratum to
show effect size. McNemar tests were also utilized to examine
whether frequency distributions of participants across the
risk factor strata changed from baseline to postintervention.
For a reference purpose, two-sample 𝑡-tests were used to
compare the magnitude of changes between Athens CHIP
and Rankin et al. [8]. Rankin et al. evaluated the results of
CHIP classes throughout multiple sites in the US, excluding
Athens.
3. Results
In this pilot study, a total of 225 people enrolled, with a
mean age of 56 years and with a range of 24–81 years, 28%
male, 72% females, as displayed in Table 1. Of those enrolled,
210 (90%) participated in all aspects of the study; 214 (95%)
completed the first and at least part of the second health
screen. The mean difference “before” and “after” biometric
value is represented in Table 2. The participants achieved
significant mean clinical changes in almost all risk factors, as
demonstrated by the 𝑃 values.
Table 2 also displays the mean changes of 5066 par-
ticipants who attended CHIP classes throughout the US,
excluding those attending the Athens classes, as reported by
Rankin et al. [8]. The findings in Athens were comparable
to those seen in Rankin et al., as demonstrated by the 𝑃: (1)
versus (2).
Table 3 displays the stratified data using conventional risk
factor categories. The data in all substrata improved in all
risk factors except those in the normal range for SBP, DBP,
and TG, as demonstrated by the 𝑃 values and Cohen’s 𝑑.
Please note that the higher the risk strata when entering the
program, the greater the improvements by the end of the
intervention.
A comparison of the risk factor reductions observed in
this study with those reported by Rankin et al. from CHIP
chapters across the United States was similar, as was the data
presented in Table 1 looking at gender and age differences
among those two groups. This was the case even though the
Athens classes attracted a wider age spread.
4. Discussion
Theaimof this studywas to validate the effectiveness of CHIP
in the rural Appalachian setting of Athens County, Ohio.
A total of 225 self-selected participants had the financial
resources available to attend the 4- to 8-week intensive,
community-based lifestyle intervention program. Chronic
disease-related risk factors responded favorably and rapidly
to the recommended lifestyle changes towards a healthier
whole food, plant-based diet coupled with daily exercise.
Those at highest risk had the greatest improvements. The
substantial changes in BMI, especially among those in the
obesity category, are remarkable in that the program empha-
sized the unrestricted use of whole foods (fruits, vegetables,
whole grains, and legumes) plus plenty of water (to replace
carbonated drinks and caffeine). The emphasis was on an
ad libitum diet without restrictions on serving size or the
amount of food eaten. The recommended daily exercise
burned insufficient calories to explain the amount of weight
loss that occurred. Unlike calorie-restrictive diets, which
leave the participant feeling hungry, the low-caloric density
of food high in fiber filled the stomach, providing satiation
naturally, and contributed to the success of the program.
These findings follow those from the Diabetes Prevention
Program (DPP), which documented the efficacy of a lifestyle
program in those at risk for diabetes [15]. Those who were
in the lifestyle arm of the study had a 58% reduction in the
diagnosis of T2DM, far better than the pharmacologic arm
using metformin (31%). The Look AHEAD trial evaluated a
lifestyle intervention for those diagnosed with T2DM [16].
The goals of this programwere to attain>7% bodyweight loss
through a calorie-restricted diet (1200–1800 daily calories,
<30% calories from fat) and a gradual increase in activity
to 175 minutes per week. The lifestyle intervention group
succeeded in losing weight and improving diabetes risk
factors (SBP, DBP, TG, and hemoglobin A1c). These two
studies are in line with results achieved in the Rockford CHIP
project [10]. In this cohort of 84 people with diabetes who
were on oral medication, 38 dropped their mean FPG by 18%.
This improvement occurred even as medication dosage was
reduced by more than 10%. Similarly, of 46 participants who
were on insulin, 18 were able to drop their mean FPG by 22%
while at the same time reducing insulin dosage by more than
10% [10].
The overall clinical changes in this pilot study are similar
to those found in other 4-week CHIP classes throughout
United States [6–8]. Other groups also have documented
large serum cholesterol drops in response to a plant-based
eating pattern [17, 18].The emphasis on substantially reducing
dietary cholesterol, as well as saturated and trans fat, while
increasing dietary fiber, may largely explain significant drops
in elevated TC and LDL levels.
The significant reductions in TC and LDL may possi-
bly explain the reduction in HDL levels, which is usually
considered detrimental. On the other hand, a systematic
review and meta-analysis has questioned this. Evaluating 108
randomized trials involving close to 300,000 participants
at risk for coronary artery disease (CAD), an international
review group concluded that “simply increasing the amount
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Table 2: Mean changes in selected risk factors in 225 participants of the Athens, OH, CHIP classes, compared to 5066 participants who
participated in CHIP interventions in the US (Rankin et al. [8]).
Variables Athens (1) Rankin study (2) 𝑃: (1) versus (2)
𝑛 Δ (%) SD 𝑃 𝑛 Δ (%) SD 𝑃
BMI (kg/m2) 208 −3.5 4.0 <0.001 4536 −3.2 3.0 <0.001 >0.2
SBP (mmHg) 203 −4.7 11.5 <0.001 4579 −4.9 18.7 <0.001 >0.2
DBP (mmHg) 203 −1.7 13.6 0.085 4577 −5.3 12.9 <0.001 <0.001
TC (mg/dL) 214 −10.3 13.2 <0.001 4674 −11.0 13.8 <0.001 >0.2
LDL (mg/dL) 210 −10.3 21.5 <0.001 4568 −13.0 21.1 <0.001 0.080
HDL (mg/dL) 214 −10.2 13.0 <0.001 4673 −4.7 8.8 <0.001 <0.001
TG (mg/dL) 214 0.0 38.0 >0.2 4669 −7.7 42.8 <0.001 0.005
FPG (mg/dL) 213 −4.1 11.1 <0.001 3689 −6.1 21.3 <0.001 0.018
of circulating HDL does not reduce the risk of CAD events,
CAD deaths, or total deaths [19].” More recently, views are
emerging that HDL may have both atheroprotective as well
as proinflammatory/atherogenic properties [20–22]. Could it
be that whole food, plant-based diets that have successfully
demonstrated the regression of CAD in response tomarkedly
lower lipid values, including HDL, may have facilitated the
conversion of HDL from a proinflammatory to an anti-
inflammatory, atheroprotective particle [23–25]?And could it
be that these properties are more important than the absolute
HDL numbers [26, 27]?
Several groups have demonstrated CAD regression [23,
24, 27–29] by utilizing a lifestyle medicine approach centered
on a simpler diet consisting of more plant-based whole
foods [23, 29]. Other researchers achieved similar results,
having included daily exercise in the program [17, 24, 29].
It not only lowers elevated blood pressure, but it also lowers
blood glucose levels and the corresponding dosage of needed
medication. At the same time, excess weight levels decrease as
participants eat, without restriction of quantity,more foods as
grown, simply prepared.
According to other studies, concurrently with improve-
ment in biomarkers and improved health, the CHIP lifestyle
intervention program is cost-effective, reducingmedical costs
for participants [30–32]. A New York Academy of Medicine
review of community prevention programs that are proven
to be effective, including CHIP, estimated that they produce
a return on investment (ROI) of 5.6 over five years [33].
Despite the evidence of effectiveness, lifestyle medical
treatment is generally underutilized. The prevalent conven-
tional one-to-one, provider-to-patient health care model is
significantly limited in the following ways. (1) The time
allocated per patient is short, averaging less than 15 minutes,
and usually spent addressing problems and prescribing or
renewing a different medication for each problem. (2) The
model incentivizes the physician to choose the quickest and
least time-intensive, but often the most expensive method
of evaluation and treatment for the patient. (3) The model
is expensive in that it requires highly trained and therefore
highly compensated providers to provide basic information
that could easily be taught in a more efficient, less expensive
way. (4) The model is driven by illness, not by wellness,
compensating providers for addressing problems, not for
maintaining health. (5) Finally, in many localities, there is
a shortage of primary care providers, leaving many who are
in need without a medical home to address prevention and
easily managed health issues. Left untended, these can then
escalate into serious problems, leading the patient to seek care
via emergency services, greatly elevating the cost of care.
CHIP, though not generally reimbursed by insurers,
historically has utilized trained volunteer facilitators. The
facilitators, who are not necessarily medical professionals,
present a prepared curriculum in a group setting, achiev-
ing remarkable results in reducing biomarkers for illness,
medication consumption, and overall health care costs. The
content in the videos and printed materials, as well as
the feedback from the initial health risk assessment, has
been demonstrated to be the key to the success of CHIP.
The results of CHIP are less dependent on the training
and professional qualification of the facilitator. CHIP can
therefore be presented more efficiently and cost-effectively
by lower-paid, nonmedical, nonprofessional facilitators in a
group setting. It is the final health risk assessment and its
consistently favorable clinical outcomes, often accompanied
by reductions in medication requirements, as well as the
understanding that the participants have become the major
contributor to their own health, which provides the needed
motivation tomaintain the new lifestyle and its health-related
benefits.
4.1. Limitations. The magnitude of the observed changes in
the biometric risk factors may relate, in part, to the self-
selection of the participants. These were people who could
afford or obtain funding for the program and thus demon-
strated their readiness for a change to improve their health
and to assume more personal responsibility for behavioral
adjustments, especially in their daily diet. There may also
be the confounder of regression to the mean, although a
randomized controlled trial of the Rockford CHIP program
discounted this as a major explanation for the magnitude of
the observed favorable changes [34]. These are only short-
termmeasures of behavioral changes. Towhat extent they can
be maintained remains to be seen, since short-term behavior
changes are subject to decay over time [35]. Future investiga-
tion needs to be targeted at the effectiveness of a maintenance
program with regularly scheduled educational meetings and
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Table 3: (a) Changes in selected chronic disease risk factors according to initial risk classification on 225 participants of the Athens, OH,
CHIP. (b) Changes in selected chronic disease risk factors according to initial risk classification on 225 participants of the Athens, OH, CHIP.
(a)
Risk factor 𝑁 𝑁 𝜒2∗ (𝑃) Baseline Post-intervention Δ Δ 𝑃 Cohen’s 𝑑
Baseline Post-intervention Mean SD Mean SD Mean %
BMI (kg/m2)
18.5–24.9 35 51
31 (<0.001)
22.7 1.7 22.3 2.6 −0.4 −1.8% >0.2 0.20
25–30 57 58 27.3 1.3 26.1 1.4 −1.2 −4.4% <0.001 1.90
>30 116 99 37.6 6.4 36.2 6.2 −1.4 −3.7% <0.001 1.51
SBP (mmHg)
<120 66 104
38 (<0.001)
111.3 8.3 113.0 10.9 1.7 1.5% 0.169 −0.17
120–139 91 78 130.3 5.6 122.7 12.1 −7.6 −5.8% <0.001 0.64
140–160 38 19 148.8 5.6 130.4 14.4 −18.4 −12.4% <0.001 1.29
>160 8 2 170.4 10.5 150.2 21.1 −20.2 −11.9% 0.01 1.24
DBP (mmHg)
<80 130 154
12 (<0.001)
70.8 6.6 71.9 8.3 1.1 1.6% 0.066 −0.16
80–89 54 39 85.0 3.3 78.9 8.1 −6.1 −7.2% <0.001 0.74
>90 19 10 94.4 2.6 82.4 8.9 −12 −12.7% <0.001 1.39
TC (mg/dL)
<160 51 108
59 (<0.001)
141.5 15.1 133.1 27.7 −8.4 −5.9% 0.009 0.38
160–199 97 63 181.2 11.7 160.8 22.1 −20.4 −11.3% <0.001 1.02
200–239 47 35 218.3 10.8 189.2 26.7 −29.1 −13.3% <0.001 1.07
240–280 16 7 253.2 10.0 233.2 25.1 −20 −7.9% 0.015 0.69
>280 3 1 303 29.7 216.3 55.7 −86.7 −28.6% 0.192 1.12
(b)
Risk factor 𝑁 𝑁 𝜒2∗ (𝑃) Baseline Post-intervention Δ Δ 𝑃 Cohen’s 𝑑
Baseline Post-intervention Mean SD Mean SD Mean %
LDL (mg/dL)
<100 78 115
52 (<0.001)
78.3 18.6 72.9 23.5 −5.4 −6.9% 0.114 0.18
100–129 67 56 115.0 8.2 99.5 18.3 −15.5 −13.5% <0.001 0.86
130–159 46 33 143.1 9.8 125.7 19.8 −17.4 −12.2% <0.001 0.94
160–190 14 6 169.4 7.0 145.6 25.1 −23.8 −14.0% 0.004 0.92
>190 5 0 210.6 19.2 141.4 29.1 −69.2 −32.9% 0.015 1.83
HDL (mg/dL)
<40 69 105
60 (<0.001)
34.9 3.7 33.4 4.6 −1.5 −4.3% 0.004 0.36
40–60 101 89 48.8 5.6 42.2 7.0 −6.6 −13.5% <0.001 1.16
>60 44 20 72.1 13.7 62.5 15.7 −9.6 −13.3% <0.001 0.86
TG (mg/dL)
<100 80 84
1.5 (>0.2)
71.3 19.0 81.3 32.8 10.0 14.0% 0.001 −0.38
100–199 102 103 143.7 29.7 133.5 43.5 −10.2 −7.1% 0.023 0.23
200–400 29 26 256.3 43.0 206.5 84.5 −49.8 −19.4% 0.002 0.63
>400 3 1 444.7 57.6 219.0 48.9 −225.7 −50.8% 0.019 4.16
FPG (mg/dL)
<110 162 181
15 (<0.001)
94.7 8.8 93.2 9.1 −1.5 −1.6% 0.021 0.18
110–125 27 18 116.2 4.0 108.1 11.9 −8.1 −7.0% <0.001 0.70
>125 24 14 169.1 52.3 131.6 29.9 −37.5 −22.2% <0.001 0.99
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at the effect of heightened community awareness and interest,
demonstrated by an increasing number of food suppliers and
restaurants selling and serving plant-based whole foods and
CHIP menu selections in the region.
5. Conclusion
Athens County is an economically struggling area with the
highest poverty rate in Ohio at 35%, with nearly 18% of the
population uninsured. To address this need, in 2010, Live
Healthy Appalachia became a regional provider of CHIP,
attempting to bring better health through education, moti-
vation, and inspiration. This retroactive analysis assessing
the cumulative effects of six CHIP classes conducted in the
Athens area by LHA has shown that self-selected participants
can respond and achieve clinical improvements not dissimilar
to those achieved from other sites across the US.
But, can this programbe applied to themanypeople living
in poverty in Appalachia with significant health issues, often
lacking transportation, adequate education, and easy access
to healthcare? Further innovative methods for presentation
and application of the principles taught in CHIP may need
to be developed and assessed, which will address the needs
of people whose situations may hinder their ability to afford,
attend, assimilate, and apply the behavioral changes currently
taught in CHIP.
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